|
1
|
Gondos A, Arndt V, Holleczek B, Stegmaier
C, Ziegler H and Brenner H: Cancer survival in Germany and the
United States at the beginning of the 21st century: an up-to-date
comparison by period analysis. Int J Cancer. 121:395–400. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
3
|
Lung T, Tascau OC, Almasan HA and Muresan
O: Head and neck cancer, treatment, evolution and post therapeutic
survival. Part 2: a decade's results 1993–2002. J Craniomaxillofac
Surg. 35:126–131. 2007.PubMed/NCBI
|
|
4
|
Warnakulasuriya S, Johnson NW and van der
Waal I: Nomenclature and classification of potentially malignant
disorders of the oral mucosa. J Oral Pathol Med. 36:575–580. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van der Waal I: Potentially malignant
disorders of the oral and oropharyngeal mucosa; terminology,
classification and present concepts of management. Oral Oncol.
45:317–323. 2009.PubMed/NCBI
|
|
6
|
Reibel J: Prognosis of oral pre-malignant
lesions: significance of clinical, histopathological, and molecular
biological characteristics. Crit Rev Oral Biol Med. 14:47–62. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pitiyage G, Tilakaratne WM, Tavassoli M
and Warnakulasuriya S: Molecular markers in oral epithelial
dysplasia: review. J Oral Pathol Med. 38:737–752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pindborg JJ, Reichart P, Smith CJ and Waal
I: World Health Organization: histological typing of cancer and
precancer of the oral mucosa. Springer-Verlag; Berlin: pp. 47–62.
1997
|
|
9
|
Warnakulasuriya S, Reibel J, Bouquot J and
Dabelsteen E: Oral epithelial dysplasia classification systems:
predictive value, utility, weaknesses and scope for improvement. J
Oral Pathol Med. 37:127–133. 2008. View Article : Google Scholar
|
|
10
|
Fleskens S and Slootweg P: Grading systems
in head and neck dysplasia: their prognostic value, weaknesses and
utility. Head Neck Oncol. 1:112009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Warnakulasuriya S: Lack of molecular
markers to predict malignant potential of oral precancer. J Pathol.
190:407–409. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ha PK, Chang SS, Glazer CA, Califano JA
and Sidransky D: Molecular techniques and genetic alterations in
head and neck cancer. Oral Oncol. 45:335–339. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nasser W, Flechtenmacher C, Holzinger D,
Hofele C and Bosch FX: Aberrant expression of p53,
p16INK4a and Ki-67 as basic biomarker for malignant
progression of oral leukoplakias. J Oral Pathol Med. 40:629–635.
2011.PubMed/NCBI
|
|
14
|
Ries J, Agaimy A, Vairaktaris E, Gorecki
P, Neukam FW, Strassburg LH and Nkenke E: Detection of MAGE-A
expression predicts malignant transformation of oral leukoplakia.
Cancer Invest. 30:495–502. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ries J, Agaimy A, Vairaktaris E, Kwon Y,
Strassburg LH, Neukam FW and Nkenke E: Evaluation of MAGE-A
expression and grade of dysplasia for predicting malignant
progression of oral leukoplakia. Int J Oncol. 41:1085–1093.
2012.PubMed/NCBI
|
|
16
|
Ries J, Ponader S, Mollaoglu N,
Vairaktaris E, Neukam FW and Nkenke E: Early findings of a novel
established molecular diagnostic technique for the prediction of
malignant transformation in leukoplakia. Mol Med Report. 2:947–952.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schaaij-Visser TB, Bremmer JF, Braakhuis
BJ, Heck AJ, Slijper M, van der Waal I and Brakenhoff RH:
Evaluation of cornulin, keratin 4, keratin 13 expression and grade
of dysplasia for predicting malignant progression of oral
leukoplakia. Oral Oncol. 46:123–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shin DM, Ro JY, Hong WK and Hittelman WN:
Dysregulation of epidermal growth factor receptor expression in
premalignant lesions during head and neck tumorigenesis. Cancer
Res. 54:3153–3159. 1994.PubMed/NCBI
|
|
19
|
Smith J, Rattay T, McConkey C, Helliwell T
and Mehanna H: Biomarkers in dysplasia of the oral cavity: a
systematic review. Oral Oncol. 45:647–653. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vairaktaris E, Serefoglou Z, Avgoustidis
D, Yapijakis C, Critselis E, Vylliotis A, Spyridonidou S, et al:
Gene polymorphisms related to angiogenesis, inflammation and
thrombosis that influence risk for oral cancer. Oral Oncol.
45:247–253. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vairaktaris E, Yapijakis C, Derka S,
Vassiliou S, Serefoglou Z, Vylliotis A, Wiltfang J, et al:
Association of platelet glycoprotein Ia polymorphism with minor
increase of risk for oral cancer. Eur J Surg Oncol. 32:455–457.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yapijakis C, Vairaktaris E, Vassiliou S,
Vylliotis A, Nkenke E, Nixon AM, Derka S, et al: The low VEGF
production allele of the +936C/T polymorphism is strongly
associated with increased risk for oral cancer. J Cancer Res Clin
Oncol. 133:787–791. 2007.
|
|
23
|
Oliveira LR and Ribeiro-Silva A:
Prognostic significance of immunohistochemical biomarkers in oral
squamous cell carcinoma. Int J Oral Maxillofac Surg. 40:298–307.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ribeiro DC, Gleber-Netto FO, Sousa SF,
Bernardes VD, Guimaraes-Abreu MH and Aguiar MC: Immunohistochemical
expression of EGFR in oral leukoplakia: association with
clinicopathological features and cellular proliferation. Med Oral
Patol Oral Cir Bucal. 17:e739–744. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nagatsuka H, Ishiwari Y, Tsujigiwa H,
Nakano K and Nagai N: Quantitation of epidermal growth factor
receptor gene amplification by competitive polymerase chain
reaction in pre-malignant and malignant oral epithelial lesions.
Oral Oncol. 37:599–604. 2001. View Article : Google Scholar
|
|
26
|
Taoudi Benchekroun M, Saintigny P, Thomas
SM, et al: Epidermal growth factor receptor expression and gene
copy number in the risk of oral cancer. Cancer Prev Res. 3:800–809.
2010.PubMed/NCBI
|
|
27
|
Srinivasan M and Jewell SD: Evaluation of
TGF-alpha and EGFR expression in oral leukoplakia and oral
submucous fibrosis by quantitative immunohistochemistry. Oncology.
61:284–292. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Srinivasan M and Jewell SD: Quantitative
estimation of PCNA, c-myc, EGFR and TGF-α in oral submucous
fibrosis - an immunohistochemical study. Oral Oncol. 37:461–467.
2001.PubMed/NCBI
|
|
29
|
Fluss R, Faraggi D and Reiser B:
Estimation of the Youden Index and its associated cutoff point.
Biom J. 47:458–472. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brennan M, Migliorati CA, Lockhart PB,
Wray D, Al-Hashimi I, Axell T, Bruce AJ, et al: Management of oral
epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 103(Suppl 19): S19.e1–S19.e12. 2007. View Article : Google Scholar
|
|
31
|
Fleskens SA, Bergshoeff VE, Voogd AC, van
Velthuysen ML, Bot FJ, Speel EJ, Kremer B, et al: Interobserver
variability of laryngeal mucosal premalignant lesions: a
histopathological evaluation. Mod Pathol. 24:892–898. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Holmstrup P, Vedtofte P, Reibel J and
Stoltze K: Oral premalignant lesions: is a biopsy reliable? J Oral
Pathol Med. 36:262–266. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Napier SS and Speight PM: Natural history
of potentially malignant oral lesions and conditions: an overview
of the literature. J Oral Pathol Med. 37:1–10. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Angiero F, Berenzi A, Benetti A, Rossi E,
Del Sordo R, Sidoni A, Stefani M and Dessy E: Expression of p16,
p53 and Ki-67 proteins in the progression of epithelial dysplasia
of the oral cavity. Anticancer Res. 28:2535–2539. 2008.PubMed/NCBI
|
|
35
|
Cruz IB, Snijders PJ, Meijer CJ, Braakhuis
BJ, Snow GB, Walboomers JM and van der Waal I: p53 expression above
the basal cell layer in oral mucosa is an early event of malignant
transformation and has predictive value for developing oral
squamous cell carcinoma. J Pathol. 184:360–368. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Feng CJ, Li HJ, Li JN, Lu YJ and Liao GQ:
Expression of Mcm7 and Cdc6 in oral squamous cell carcinoma and
precancerous lesions. Anticancer Res. 28:3763–3769. 2008.PubMed/NCBI
|
|
37
|
Grandis JR and Tweardy DJ: TGF-alpha and
EGFR in head and neck cancer. J Cell Biochem. (Suppl 17): 188–191.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rautava J, Jee KJ, Miettinen PJ, Nagy B,
Myllykangas S, Odell EW, Soukka T, et al: ERBB receptors in
developing, dysplastic and malignant oral epithelia. Oral Oncol.
44:227–235. 2008. View Article : Google Scholar : PubMed/NCBI
|
